PDF herunterladen
CC BY-NC-ND 4.0 · Endosc Int Open 2020; 08(12): E1862-E1864
DOI: 10.1055/a-1293-7890
Editorial

EUS-guided fine needle biopsy sampling in autoimmune pancreatitis: Is needle tip design more important than needle size?

Per Hedenström
1   Division of Medical Gastroenterology, Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
2   Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
,
Björn Lindkvist
1   Division of Medical Gastroenterology, Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
2   Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

Endosonographers encounter a lot of puzzling situations and conditions. One such condition is autoimmune pancreatitis (AIP). The typical radiological presentation in autoimmune pancreatitis is a “sausage-shaped” pancreas with parenchymal enlargement, peripancreatic halo, and a general narrowing of the pancreatic duct [1]. However, AIP can also present with a focal pancreatic mass that may be impossible to distinguish from pancreatic ductal adenocarcinoma (PDAC) solely based on imaging [2] [3]. Clinical management of AIP and PDAC are completely different and misdiagnosis of AIP as PDAC may have deleterious consequences for the patient, including unnecessary and extensive pancreatic surgery, chemotherapy, and withholding of a potentially curative treatment (corticosteroids and/or other immunosupressants) [2] [4] [5]. Moreover, the prognosis for AIP is far better than for PDAC, with long-term survival to be expected in the majority of patients.



Publikationsverlauf

Artikel online veröffentlicht:
27. November 2020

© 2020. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

Einführung zu:

Utility of endoscopic ultrasound-guided fine-needle biopsy in the diagnosis of type 1 autoimmune pancreatitisEndosc Int Open 2020; 08(12): E1855-E1861
DOI: 10.1055/a-1236-3266

 

  • References

  • 1 Löhr JM, Beuers U, Vujasinovic M. et al. European Guideline on IgG4-related digestive disease – UEG and SGF evidence-based recommendations. United Europ Gastroenterol J 2020; 8: 637-666
    CrossrefPubMedGoogle Scholar
  • 2 Fritz S, Bergmann F, Grenacher L. et al. Diagnosis and treatment of autoimmune pancreatitis types 1 and 2. Br J Surg 2014; 101: 1257-1265
    CrossrefPubMedGoogle Scholar
  • 3 Agrawal S, Daruwala C, Khurana J. Distinguishing autoimmune pancreatitis from pancreaticobiliary cancers: current strategy. Ann Surg 2012; 255: 248-258
    CrossrefPubMedGoogle Scholar
  • 4 Gardner TB, Levy MJ, Takahashi N. et al. Misdiagnosis of autoimmune pancreatitis: a caution to clinicians. Am J Gastroenterol 2009; 104: 1620-1623
    CrossrefPubMedGoogle Scholar
  • 5 Ivan Heerde MJ, Biermann K, Zondervan PE. et al. Prevalence of autoimmune pancreatitis and other benign disorders in pancreatoduodenectomy for presumed malignancy of the pancreatic head. Dig Dis Sci 2012; 57: 2458-2465
    CrossrefPubMedGoogle Scholar
  • 6 Chari ST. Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinicʼs HISORt criteria. J Gastroenterol 2007; 42: 39-41
    CrossrefPubMedGoogle Scholar
  • 7 Chang MC, Liang PC, Jan S. et al. Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels. Pancreatology 2014; 14: 366-372
    CrossrefPubMedGoogle Scholar
  • 8 Shimosegawa T, Chari ST, Frulloni L. et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 2011; 40: 352-358
    CrossrefPubMedGoogle Scholar
  • 9 Song TJ, Kim MH, Kim MJ. et al. Clinical validation of the international consensus diagnostic criteria and algorithms for autoimmune pancreatitis: combined IAP and KPBA meeting 2013 report. Pancreatology 2014; 14: 233-237
    CrossrefPubMedGoogle Scholar
  • 10 Buscarini E, De Lisi S, Arcidiacono PG. et al. Endoscopic ultrasonography findings in autoimmune pancreatitis. World J Gastroenterol 2011; 17: 2080-2085
    CrossrefPubMedGoogle Scholar
  • 11 Kamisawa T, Ohara H, Kim MH. et al. Role of endoscopy in the diagnosis of autoimmune pancreatitis and immunoglobulin G4-related sclerosing cholangitis. Digest Endosc 2014; 26: 627-635
    CrossrefPubMedGoogle Scholar
  • 12 Chari ST, Takahashi N, Levy MJ. et al. A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol 2009; 7: 1097-1103
    CrossrefPubMedGoogle Scholar
  • 13 Hebert-Magee S, Bae S, Varadarajulu S. et al. The presence of a cytopathologist increases the diagnostic accuracy of endoscopic ultrasound-guided fine needle aspiration cytology for pancreatic adenocarcinoma: a meta-analysis. Cytopathology 2013; 24: 159-171
    CrossrefPubMedGoogle Scholar
  • 14 Hewitt MJ, McPhail MJ, Possamai L. et al. EUS-guided FNA for diagnosis of solid pancreatic neoplasms: a meta-analysis. Gastrointest Endosc 2012; 75: 319-331
    CrossrefPubMedGoogle Scholar
  • 15 Cao L, Wang Y, Wang J. et al. The role of EUS-guided fine needle aspiration in autoimmune pancreatitis: a single center prospective study. Scand J Gastroenterol 2018; 53: 1604-1610
    CrossrefPubMedGoogle Scholar
  • 16 Kanno A, Masamune A, Fujishima F. et al. Diagnosis of autoimmune pancreatitis by EUS-guided FNA using a 22-gauge needle: a prospective multicenter study. Gastrointest Endosc 2016; 84: 797-804.e791
    CrossrefPubMedGoogle Scholar
  • 17 Morishima T, Kawashima H, Ohno E. et al. Prospective multicenter study on the usefulness of EUS-guided FNA biopsy for the diagnosis of autoimmune pancreatitis. Gastrointest Endosc 2016; 84: 241-248
    CrossrefPubMedGoogle Scholar
  • 18 de Moura DTH, McCarty TR, Jirapinyo P. et al. EUS-guided fine-needle biopsy sampling versus FNA in the diagnosis of subepithelial lesions: a large multicenter study. Gastrointest Endosc 2020; 92: 108-119.e103
    CrossrefPubMedGoogle Scholar
  • 19 Hedenstrom P, Marschall HU, Nilsson B. et al. High clinical impact and diagnostic accuracy of EUS-guided biopsy sampling of subepithelial lesions: a prospective, comparative study. Surg Endosc 2018; 32: 1304-1313
    CrossrefPubMedGoogle Scholar
  • 20 Iwashita T, Yasuda I, Doi S. et al. Use of samples from endoscopic ultrasound-guided 19-gauge fine-needle aspiration in diagnosis of autoimmune pancreatitis. Clin Gastroenterol Hepatol 2012; 10: 316-322
    CrossrefPubMedGoogle Scholar
  • 21 Kurita A, Yasukawa S, Zen Y. et al. Comparison of a 22-gauge Franseen-tip needle with a 20-gauge forward-bevel needle for the diagnosis of type 1 autoimmune pancreatitis: a prospective, randomized, controlled, multicenter study (COMPAS study). Gastrointest Endosc 2020; 91: 373-381.e372
    CrossrefPubMedGoogle Scholar
  • 22 Ishikawa T, Kawashima H, Ohno E. et al. Usefulness of endoscopic ultrasound-guided fine-needle biopsy for the diagnosis of autoimmune pancreatitis using a 22-gauge Franseen needle: a prospective multicenter study. Endoscopy 2020; DOI: 10.1055/a-1183-3583.
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 23 Bang JY, Hebert-Magee S, Navaneethan U. et al. Randomized trial comparing the Franseen and fork-tip needles for EUS-guided fine-needle biopsy sampling of solid pancreatic mass lesions. Gastrointest Endosc 2018; 87: 1432-1438
    CrossrefPubMedGoogle Scholar